Taking on analysts’ expectations and winning: Abcam plc (ABCM)

Abcam plc (NASDAQ: ABCM) stock fell -0.96% on Tuesday to $16.50 against a previous-day closing price of $16.66. With 0.77 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.74 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $17.32 whereas the lowest price it dropped to was $16.10. The 52-week range on ABCM shows that it touched its highest point at $18.38 and its lowest point at $12.48 during that stretch. It currently has a 1-year price target of $19.92.

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of ABCM was down-trending over the past week, with a drop of -4.24%, but this was up by 2.74% over a month. Three-month performance surged to 16.20% while six-month performance rose 0.73%. The stock gained 13.71% in the past year, while it has gained 6.04% so far this year.

Float and Shares Shorts:

At present, 228.80 million ABCM shares are outstanding with a float of 214.54 million shares on hand for trading. On Apr 27, 2023, short shares totaled 0.71 million, which was 0.31% higher than short shares on Mar 30, 2023. In addition to Mr. Alan Thomas Hirzel BS, M.B.A., M.S., MBA, MS as the firm’s CEO & Exec. Director, Mr. Michael Shaun Baldock B.A. serves as its CFO & Director.

Institutional Ownership:

Through their ownership of 80.73% of ABCM’s outstanding shares, institutional investors have majority control over the company. Other institutions hold 45.37% of ABCM, in contrast to 38.17% held by mutual funds. Shares owned by individuals account for –. As the largest shareholder in ABCM with 7.61% of the stake, Durable Capital Partners LP holds 17,460,597 shares worth 17,460,597. A second-largest stockholder of ABCM, Wellington Management Co. LLP, holds 14,655,158 shares, controlling over 6.39% of the firm’s shares. Harding Loevner LP is the third largest shareholder in ABCM, holding 13,805,588 shares or 6.02% stake. With a 3.83% stake in ABCM, the T Rowe Price New Horizons Fund is the largest stakeholder. A total of 8,771,174 shares are owned by the mutual fund manager. The Vanguard Health Care Fund, which owns about 3.12% of ABCM stock, is the second-largest Mutual Fund holder. It holds 7,161,997 shares valued at 116.67 million. Brown Capital Management – Intern holds 2.91% of the stake in ABCM, owning 6,672,099 shares worth 108.69 million.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for ABCM since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With ABCM analysts setting a high price target of $19.89 and a low target of $13.87, the average target price over the next 12 months is $16.02. Based on these targets, ABCM could surge 20.55% to reach the target high and fall by -15.94% to reach the target low. Reaching the average price target will result in a decline of -2.91% from current levels.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy.

Dividends & Yield:

In terms of dividends, ABCM has a dividend of $0.13 is likely to be paid on average over the next five years. Dividend yield is another indicator that appeals to many investors, and ABCM currently yields $0.21. In the past year, ABCM’s dividend yield has been $0.21, but when looking at the stock over the past five years, its yield has been $0.80.